Prostaglandin catabolic enzymes as tumor suppressors

Cancer and Metastasis Reviews

Volumn 30, Issue 3-4, 2011, Pages 409-417

  Tai, Hsin Hsiung ^a  

^a University of Kentucky   (United States)

Author keywords

Cancer chemoprevention; Cyclooxygenase; Prostaglandin dehydrogenase; Prostaglandin reductase; Prostanoids; Tumor suppressor

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; 15 OXOPROSTAGLANDIN 13 REDUCTASE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 5 AZA 2' DEOXYCYTIDINE; 6 (1,3 DIOXO 1H,3H BENZO[DE]ISOQUINOLIN 2 YL) N HYDROXYHEXANAMIDE; APICIDIN; CALCITRIOL; CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; DICLOFENAC; ERLOTINIB; FLURBIPROFEN; INDOMETACIN; LEUKOTRIENE B4; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXAMFLATIN; PIOGLITAZONE; PROSTAGLANDIN; PROSTAGLANDIN E SYNTHASE 1; ROSIGLITAZONE; SILIBININ; TRICHOSTATIN A;

ADENOMATOUS POLYP; APOPTOSIS; BLADDER CARCINOMA; BREAST CARCINOMA; CANCER GENE THERAPY; CANCER INHIBITION; CARDIOVASCULAR DISEASE; CHEMOPROPHYLAXIS; CLINICAL TRIAL (TOPIC); COLON ADENOMA; COLON CANCER; CROHN DISEASE; DOWN REGULATION; ENZYME ACTIVITY; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; HUMAN; LUNG TUMOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH; ULCERATIVE COLITIS;

15-OXOPROSTAGLANDIN 13-REDUCTASE; ANIMALS; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; NEOPLASMS; PROSTAGLANDINS; TUMOR SUPPRESSOR PROTEINS;

EID: 83855160829     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-011-9314-z     Document Type: Review

References (66)

1. WL Smith DL DeWitt RM Garavito 2000 Cyclooxygenases: Structural, cellular and molecular biology Annual Review of Biochemistry 69 145 182 10966456 10.1146/annurev.biochem.69.1.145 1:CAS:528:DC%2BD3cXnt1ajtLg%3D
2. HH Tai H Cho M Tong YF Ding 2006 15-Hydroxyprostaglandin dehydrogenase: Structure and biological functions Current Pharmaceutical Design 12 955 962 16533162 10.2174/138161206776055958 1:CAS:528:DC%2BD28XitF2rsrY%3D
3. D Wang RN DuBois 2006 Prostaglandins and cancer Gut 55 115 122 16118353 10.1136/gut.2004.047100 1:CAS:528:DC%2BD28Xnt1yquw%3D%3D
4. K Muller-Deeker G Furstenberger 2007 The cyclooxygenase-2-mediated prostaglandin signaling is casually related to epithelial carcinogenesis Molecular Carcinogenesis 46 705 710 10.1002/mc.20326
5. JE Celis M Ostergaard B Basse A Celis JB Lauridsen GP Ratz, et al. 1996 Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progress of human bladder transitional carcinoma Cancer Research 56 4782 4790 8840999 1:CAS:528:DyaK28XmsV2itL8%3D
6. JR Gee RG MOntaya HM Khaled AL Sabichi HB Grossman 2003 Cytokeratin 20, AN43, PGDH and COX-2 expression in transitional and squamous cell carcinoma of the bladder Urological Oncology 21 266 270 1:CAS:528:DC%2BD3sXmvVyhuro%3D
7. S Tseng-Rogenski J Gee KW Ignatoski LP Kunju A Bucheit HJ Kinter, et al. 2010 Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression American Journal of Pathology 176 1462 1468 20093479 10.2353/ajpath.2010.090875 1:CAS:528:DC%2BC3cXktVOisbk%3D
8. +-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer Carcinogenesis 26 65 72 15358636 10.1093/carcin/bgh277 1:CAS:528:DC%2BD2MXisVSguw%3D%3D
9. L Yang JM Amann T Kikuchi R Porta M Guix A Gonzalez, et al. 2007 Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer Cancer Research 67 5587 5593 17575121 10.1158/0008-5472.CAN-06-2287 1:CAS:528:DC%2BD2sXmsFCqs78%3D
10. +-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small-cell lung cancer Cancer Prevention Research 1 241 249 19138967 10.1158/1940-6207.CAPR-08-0055 1:CAS:528:DC%2BC3cXptFOisbc%3D
11. M Yan RM Rerko P Platzer D Dawson J Willis M Tong, et al. 2004 15-Hydroxyprostaglandin dehydrogenase, a COX-2 antagonist, is a TGF-β-induced suppressor of human gastrointestinal cancers Proceedings of the National Academy of Sciences of the United States of America 10 17468 17473 10.1073/pnas.0406142101
12. MG Backlund JR Mann VR Holla FG Buchanan HH Tai ES Musiek, et al. 2005 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer Journal of Biological Chemistry 280 3217 3223 15542609 10.1074/jbc.M411221200 1:CAS:528:DC%2BD2MXovVCrug%3D%3D
13. I Wolf J Okelly T Rubinek M Tong A Nguyen BT Lin, et al. 2006 15-Hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer Cancer Research 66 7818 7823 16885386 10.1158/0008-5472.CAN-05-4368 1:CAS:528:DC%2BD28XnsFyqs7o%3D
14. 3 in breast cancer Anticancer Research 30 1673 1679 20592360 1:CAS:528:DC%2BC3cXhtVWmu7zI
15. JE Celis P Gromov T Cabezon JMA Moreia E Friis K Jirstrom, et al. 2008 15-Hydroxyprostaglandin dehydrogenase alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma Molecular & Cellular Proteomics 7 1795 1809 10.1074/mcp.R800011-MCP200 1:CAS:528:DC%2BD1cXht1Ols7%2FP
16. 2) serum level in ovarian cancer patients The Journal of Steroid Biochemistry and Molecular Biology 121 387 390 20304053 10.1016/j.jsbmb.2010.03.049 1:CAS:528:DC%2BC3cXptVGjsL0%3D
17. Z Liu X Wang Y Lu S Han F Zhang H Zhai, et al. 2008 Expression of 15-PGDH is down-regulated by COX-2 in gastric cancer Carcinogenesis 29 1219 1227 18174234 10.1093/carcin/bgm297 1:CAS:528:DC%2BD1cXot1Wjtr8%3D
18. A Thiel A Ganesan J Mrena S Junnila A Nykanen A Hemmes, et al. 2009 15-Hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer Clinical Cancer Research 15 4572 4580 19584167 10.1158/1078-0432.CCR-08-2518 1:CAS:528:DC%2BD1MXosV2lt7g%3D
19. H Tatsuwaki T Tanigawa T Watanabe H Machida H Okazaki H Yamagami, et al. 2010 Reduction of 15-hydroxyprostaglandin dehydrogenase expression is an independent predictor of poor survival associated with enhanced cell proliferation in gastric adenocarcinoma Cancer Science 101 550 558 19917058 10.1111/j.1349-7006.2009.01390.x 1:CAS:528:DC%2BC3cXivFequrs%3D
20. HJ Song SJ Myung IW Kim JY Jeong YS Park SM Lee, et al. 2011 15-Hydroxyprostaglandin dehydrogenase is down-regulated and exhibits tumor suppressor activity in gastric cancer Cancer Investigation 29 257 265 21469975 10.3109/07357907.2011.568562 1:CAS:528:DC%2BC3MXksVeiur0%3D
21. NJ Yoo EG Jeong SH Lee 2007 Expression of 15-hydroxyprostaglandin dehydrogenase, a COX-2 antagonist and tumor suppressor is not altered in gastric carcinomas Pathology 39 174 175 17365836 10.1080/00313020601123946
22. 2 in pancreatic tumors Pancreas 39 332 339 19820419 10.1097/MPA.0b013e3181baecbe 1:CAS:528:DC%2BC3cXjvVSht7s%3D
23. B Hoeft J Linseisen L Beckmann K Muller-Decker F Canzian A Husing, et al. 2010 Polymorphisms in fatty acid metabolism-related genes are associated with colorectal cancer risk Carcinogenesis 31 466 472 20042636 10.1093/carcin/bgp325 1:CAS:528:DC%2BC3cXivFGmsro%3D
24. +-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-α American Journal of Physiology 290 G361 368 16195422 1:CAS:528:DC%2BD28XhsFKhtbw%3D
25. JC Lousse S Defrere S Colette A Van Langendonckt J Dormez 2010 Expression of eicosanoid biosynthetic and catabolic enzymes in peritoneal endometriosis Human Reproduction 25 734 741 20023295 10.1093/humrep/dep408 1:CAS:528:DC%2BC3cXitFeit7g%3D
26. BL Judson A Miyaki VD Kekatpure B Du P Gilleaudeau M Sullivan-Whalen, et al. 2010 UV radiation inhibits 15-hydroxyprostaglandin dehydrogenase levels in human skin: evidence of transcriptional suppression Cancer Prevention Research 3 1104 1111 20643784 10.1158/1940-6207.CAPR-10-0089 1:CAS:528:DC%2BC3cXht1Gju77F
27. S Uppal CP Diggle IM Carr CW Fishwick M Ahmed GH Ibrahim, et al. 2008 Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy Nature Genetics 40 789 793 18500342 10.1038/ng.153 1:CAS:528:DC%2BD1cXmsVejtr8%3D
28. M Tong Y Ding HH Tai 2007 Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells Carcinogenesis 27 2170 2179 10.1093/carcin/bgl053
29. C Lennon MG Carlson DM Nelson Y Sadovsky 1999 In vitro modulation of the expression of 15-hydroxyprostaglandin dehydrogenase by trophoblast differentiation American Journal of Obstetrics and Gynecology 180 690 695 10076149 10.1016/S0002-9378(99)70274-7 1:CAS:528:DyaK1MXitFCntb0%3D
30. J Moreno AV Krishnan S Swami I Nonn DM Peehl D Feldman 2005 Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells Cancer Research 65 7919 7925 10.1158/0008-5472.CAN-05-0884
31. AV Krishnan S Swami D Feldman 2010 Vitamin D and breast cancer: Inhibition of estrogen synthesis and signaling The Journal of Steroid Biochemistry and Molecular Biology 121 343 348 20156557 10.1016/j.jsbmb.2010.02. 009 1:CAS:528:DC%2BC3cXptVGjs7s%3D
32. 2 activates β-catenin in human cholangiocarcinoma cells: Evidence for inhibition of these signaling pathways by ω3 polyunsaturated fatty acids Cancer Research 68 553 560 18199552 10.1158/0008-5472.CAN-07-2295 1:CAS:528:DC%2BD1cXmt1Olsg%3D%3D
33. K Lim C Han Y Dai M Shen T Wu 2009 Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking β-catenin and cylcooxygenase-2 Molecular Cancer Therapeutics 8 3046 3055 19887546 10.1158/1535-7163.MCT-09-0551 1:CAS:528:DC%2BD1MXhtlyrt7%2FN
34. 2 The FASEB Journal 25 2408 2417 21450910 10.1096/fj.10-179473 1:CAS:528:DC%2BC3MXovVCrt7w%3D
35. 2 catabolism in myeloid cells Journal of Leukocyte Biology 88 839 848 20587738 10.1189/jlb.1209821 1:CAS:528: DC%2BC3cXhsVeitr7F
36. E Eruslanov S Kaliberov I Daurkin L Kaliberova D Buchabaam J Vieweg, et al. 2009 Altered expression of 15-hydroxyprostaglandin dehydrogenase in tumor-infiltrated CD11b myeloid cells: A mechanism for immune evasion in cancer Journal of Immunology 182 7548 7557 10.4049/jimmunol.0802358 1:CAS:528:DC%2BD1MXmslCnsL4%3D
37. +-linked 15-hydroxyprostaglandin dehydrogenase expression Molecular Cancer Therapeutics 8 3130 3139 19887544 10.1158/1535-7163.MCT-09-0270 1:CAS:528:DC%2BD1MXhtlyrt7%2FF
38. M Li J Xie L Cheng B Chang Y Wang X Lan, et al. 2008 Suppression of invasive properties of colorectal carcinoma SW480 cells by 15- hydroxyprostaglandin dehydrogenase gene Cancer Investigation 26 905 912 19034772 10.1080/07357900802146154 1:CAS:528:DC%2BD1cXhsVCms7%2FL
39. S Myung RM Rerko M Yan P Platzer K Guda A Dotson, et al. 2006 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis Proceedings of the National Academy of Sciences of the United States of America 103 12098 12102 16880406 10.1073/pnas.0603235103 1:CAS:528:DC%2BD28Xotlyju7Y%3D
40. M Yan SJ Myung SP Fink E Lawrence J Lutterbaugh, et al. 2009 15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors Proceedings of the National Academy of Sciences of the United States of America 106 9409 9413 19470469 10.1073/pnas.0902367106 1:CAS:528:DC%2BD1MXot1CgurY%3D
41. +-dependent 15-hydroxyprostaglandin dehydrogenase gene promote is controlled by Ets and activating protein-1 transcriptional factors and progesterone Endocrinology 141 581 597 10650939 10.1210/en.141.2.581 1:CAS:528:DC%2BD3cXmvFClsQ%3D%3D
42. 2 and promotes cancer progression Cancer Research 66 6649 6656 16818638 10.1158/0008-5472.CAN-06-1787 1:CAS:528:DC%2BD28XmsVamtbg%3D
43. MG Backlund JR Mann VR Holla Q Shi T Daikoku SK Dey, et al. 2008 Repression of 15-hydroxyprostaglandin dehydrogenase involved histone deacetylase 2 and snail in colorectal cancer Cancer Research 68 9331 9337 19010907 10.1158/0008-5472.CAN-08-2893 1:CAS:528:DC%2BD1cXhtlOmt7vO
44. M Tong Y Ding HH Tai 2006 Histone deacetylase inhibitors and transforming growth factor-β induce 15-hydroxyprostaglandin dehydrogenase expression in human lung adenocarcinoma cells Biochemical Pharmacology 72 701 709 16844092 10.1016/j.bcp.2006.06.004 1:CAS:528:DC%2BD28XotlWgt7g%3D
45. X Chi BM Freeman M Tong Y Zhao HH Tai 2009 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer H29 cells Archives of Biochemistry and Biophysics 487 139 145 19501039 10.1016/j.abb.2009.05.017 1:CAS:528:DC%2BD1MXotl2lt70%3D
46. D Lodygin A Epanchintsev A Menssen J Diebold H Hermeking 2005 Functional epigenomics identifies genes frequently silenced in prostate cancer Cancer Research 65 4218 4227 15899813 10.1158/0008-5472.CAN-04-4407 1:CAS:528:DC%2BD2MXktlSmtrk%3D
47. LJ Marnett 2009 Mechanisms of cyclooxygenase-2 inhibition and cardiovascular side effects-The plot thickens Cancer Prevention Research 2 288 290 19336721 10.1158/1940-6207.CAPR-09-0033 1:CAS:528:DC%2BC3cXptFKguro%3D
48. Y Cha RN DuBois 2007 NSAIDs and cancer prevention: Targets downstream of COX-2 Annual Review of Medicine 58 239 252 17100552 10.1146/annurev.med.57. 121304.131253 1:CAS:528:DC%2BD2sXisV2jsbc%3D
49. SM Dubinett JT Mao S Hazra 2008 Focusing downstream in lung cancer prevention: 15-Hydroxyprostaglandin dehydrogenase Cancer Prevention Research 1 223 225 19138963 10.1158/1940-6207.CAPR-08-0148 1:CAS:528:DC%2BC3cXptFOisbg%3D
50. SD Markowitz 2008 Colorectal neoplasia goes with the flow: Prostaglandin transport and termination Cancer Prevention Research 1 77 79 19138938 10.1158/1940-6207.CAPR-08-0009 1:CAS:528:DC%2BC3cXptFOisLk%3D
51. M Tong HH Tai 2005 15-Hydroxyprostaglandin dehydrogenase can be induced by dexamethasone and other glucocorticoids at the therapeutic level in A549 human lung adenocarcinoma cells Archives of Biochemistry and Biophysics 435 50 55 15680906 10.1016/j.abb.2004.11.031 1:CAS:528:DC%2BD2MXos1GmtA%3D%3D
52. M Frenkian E Pidoux C Baudoin N Segond A Jullienne 2001 Indomethacin increases 15-PGDH expression in HL60 cells differentiated by PMA Prostaglandins, Leukotrienes, and Essential Fatty Acids 64 87 93 11237475 10.1054/plef.2001. 0246 1:CAS:528:DC%2BD3MXitlSksLs%3D
53. M Frenkian N Segond E Pidoux R Cohen A Jullienne 2001 Indomethacin, a COX inhibitor, enhances 15-PGDH and decreases human tumerol C cells proliferation Prostaglandins & Other Lipid Mediators 65 11 20 10.1016/S0090-6980(01)00116- 2 1:CAS:528:DC%2BD3MXltFKktL8%3D
54. N Wakimoto I Wolf D Yin J O'Kelly T Akagi L Abramovitz, et al. 2008 Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase Cancer Research 68 6978 6986 18757412 10.1158/0008-5472.CAN-07- 5675 1:CAS:528:DC%2BD1cXhtVCrs73K
55. Tai, H. H., Chi, X. & Tong, M. (2011) Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs). Prostaglandins and Other Lipid Mediators (in press).
56. 2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase Molecular Pharmacology 71 1715 1720 17412838 10.1124/mol.106.033357 1:CAS:528: DC%2BD2sXmt1Wqur8%3D
57. AV Krishnan S Srinivas D Feldman 2009 Inhibition of prostaglandin synthesis and actions contributes to the beneficial effects of calcitriol in prostate cancer Dermato-Endocrinology 1 7 11 20046582 10.4161/derm.1.1.7106 1:CAS:528:DC%2BD1MXps1Ohurc%3D
58. RP Singh M Gu R Agarwal 2008 Silibilin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis Cancer Research 68 2043 2050 18339887 10.1158/0008-5472.CAN-07-6247 1:CAS:528:DC%2BD1cXjtFOht7o%3D
59. M Spinola F Colombo S Falvella TA Dragani 2007 N6-Isopentenyladenosine: A potential therapeutic agent for a variety of epithelial cancers International Journal of Cancer 120 2744 2748 10.1002/ijc.22601 1:CAS:528:DC%2BD2sXkslGiu7k%3D
60. X Chi HH Tai 2010 Interleukin-4 up-regulates 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in human lung cancer cells Experimental Cell Research 316 2251 2259 20632471 10.1016/j.yexcr.2010.06.001 1:CAS:528: DC%2BC3cXos1yntrc%3D
61. 2 synthesis by interleukin-1β is amplified by interferons but inhibited by interleukin-4 in human amnion-derived WISH cells Biochimica et Biophysica Acta 1310 48 52 9244174 10.1016/0167-4889(95)00144-1
62. 2 production in human non-small-cell lung cancer Biochemical and Biophysical Research Communications 343 995 1001 16574063 10.1016/j.bbrc.2006.03.073 1:CAS:528:DC%2BD28XksFaitbY%3D
63. G Huang R Eisenberg M Yan S Monti E Lawrence P Fu, et al. 2008 15-Hydroxyprostaglandin dehydrogenase is a target of heptocyte nuclear factor 3β and a tumor suppressor in lung cancer Cancer Research 68 5040 5048 18593902 10.1158/0008-5472.CAN-07-6575 1:CAS:528:DC%2BD1cXnvFOqtL0%3D
64. T Nomura R Lu JA Satriano, et al. 2004 The two-step model of prostaglandin signal termination: In vitro reconstitution with the prostaglandin transporter and prostaglandin 15-dehydrogenase Molecular Pharmacology 65 973 978 15044627 10.1124/mol.65.4.973 1:CAS:528:DC%2BD2cXivFaltb4%3D
65. VR Holla MG Backlund P Yang RA Newman RN DuBois 2008 Regulation of prostaglandin transporters in colorectal neoplasia Cancer Prevention Research 1 93 99 19138942 10.1158/1940-6207.CAPR-07-0009 1:CAS:528:DC%2BC3cXptFOisLc%3D
66. 4-12-hydroxydehydrogenase/15-oxo-prostaglandin 13-reductase expression inhibits lung cancer growth in vitro and in vivo Lung Cancer 68 161 169 19595472 10.1016/j.lungcan.2009.06.011